Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review

por Walraven, Janneke E. W., van der Hel, Olga L., van der Hoeven, J. J. M., Lemmens, Valery E. P. P., Verhoeven, Rob H. A., Desar, Ingrid M. E.
Publicado 2022

Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial

por Schneider, T. C., de Wit, D., Links, T. P., van Erp, N. P., van der Hoeven, J. J. M., Gelderblom, H., van Wezel, T., van Eijk, R., Morreau, H., Guchelaar, H. J., Kapiteijn, E.
Publicado 2015

The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study

por Bruynzeel, A M E, Niessen, H W M, Bronzwaer, J G F, van der Hoeven, J J M, Berkhof, J, Bast, A, van der Vijgh, W J F, van Groeningen, C J
Publicado 2007

Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation

por Tol, J., Cats, A., Mol, L., Koopman, M., Bos, M. M. E. M., van der Hoeven, J. J. M., Antonini, N. F., van Krieken, J. H. J. M., Punt, C. J. A.
Publicado 2008

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer

por van Uden, D. J. P., van Maaren, M. C., Strobbe, L. J. A., Bult, P., van der Hoeven, J. J., Siesling, S., de Wilt, J. H. W., Blanken-Peeters, C. F. J. M.
Publicado 2019

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer

por van Uden, Dominique J. P., van Maaren, Marissa C., Bult, Peter, Strobbe, Luc J. A., van der Hoeven, J. J. M., Blanken-Peeters, Charlotte F. J. M., Siesling, Sabine, de Wilt, Johannes H. W.
Publicado 2019

Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer

por de Wit, D., Schneider, T. C., Moes, D. J. A. R., Roozen, C. F. M., den Hartigh, J., Gelderblom, H., Guchelaar, H. J., van der Hoeven, J. J., Links, T. P., Kapiteijn, E., van Erp, N. P.
Publicado 2016

Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics

por Schipper, L.J., Samsom, K.G., Snaebjornsson, P., Battaglia, T., Bosch, L.J.W., Lalezari, F., Priestley, P., Shale, C., van den Broek, A.J., Jacobs, N., Roepman, P., van der Hoeven, J.J.M., Steeghs, N., Vollebergh, M.A., Marchetti, S., Cuppen, E., Meijer, G.A., Voest, E.E., Monkhorst, K.
Publicado 2022

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

por de Groot, S., Janssen, L. G. M., Charehbili, A., Dijkgraaf, E. M., Smit, V. T. H. B. M., Kessels, L. W., van Bochove, A., van Laarhoven, H. W. M., Meershoek-Klein Kranenbarg, E., van Leeuwen-Stok, A. E., van de Velde, C. J. H., Putter, H., Nortier, J. W. R., van der Hoeven, J. J. M., Pijl, H., Kroep, J. R.
Publicado 2015